Skip to content

Evaluation of Different Anesthesia for Uterine Curettage

Evaluation of the Anesthetic Efficacy of Propofol,Sevoflurane and Paracervical Block for Uterine Curettage

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00733564
Acronym
EDAUC
Enrollment
150
Registered
2008-08-13
Start date
2008-08-31
Completion date
2009-03-31
Last updated
2009-03-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Abortion, Induced, Uterine Curettage

Keywords

Local anesthetic, Propofol, Sevoflurane

Brief summary

Anesthesia during uterine curettage is a problem. Paracervical block is used in general for such an operation, though, the anesthetic efficacy is incomplete. Propofol is the short-lasting intravenous anesthetic administrated popularly. Sevoflurane is a new inhalational anesthetic well-known for it's easy come, easy go property. The investigators hypothesized that propofol, sevoflurane and paracervical block had different anesthetic efficacy during uterine curettage. Which one is the optimal selection for such operation needed to be evaluated.

Interventions

DRUGLidocaine

Paracervical injection of 2% Lidocaine to block associated nociception input

DRUGPropofol

Propofol 3mg/kg will be injected intravenously; 1 mg/kg will be added additionally for incomplete anesthesia

DRUGSevoflurane

Sevoflurane 8% for anesthesia induction, 2-3% as the maintenance

Sponsors

Nanjing Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
19 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* ASA status I-II * Performing abortion operation (medical- or surgical) * Requiring painless abortion

Exclusion criteria

* \< 19 yrs, and \>=45 yrs * History of central active drugs administration * Drug abuse * Hypertension * Diabetes * Any other chronic diseases * Allergy to the study drugs * Habit of over-volume alcohol drinking * Records of history of centrally active drug use and psychiatry * Any organic disorder

Design outcomes

Primary

MeasureTime frame
Bispectral Index (BIS) value0, 5, 10, 20, 30min after anesthesia

Secondary

MeasureTime frame
Vital signs0, 5, 10, 15, 20, 25, 30min after anesthesia
Arterial blood gas analysis5min before operation; 1min and 5min after beginning of the operation
Pain intensity0, 5, 10, 20, 30min after surgical procedures
Intraoperative awareness0, 5, 10, 20, 30min after anesthesia
Side effects30min after operation
Uterine bleeding0min after completion of the operation; 1 hour after the operation
Cortisol level30min before operation; 1 and 5min during operation

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026